Tumor angiogenesis and expression of thymidine phosphorylase/platelet derived endothelial cell growth factor in human gastric carcinoma

Cancer Letters

Volumn 108, Issue 2, 1996, Pages 281-290

  Tanigawa, N ^a   Amaya, H ^a   Matsumura, M ^a   Katoh, Y ^a   Kitaoka, A ^a   Aotake, T ^a   Shimomatsuya, T ^a   Rosenwasser, O A ^a   Iki, M ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Gastric carcinoma; Microvessel count; Platelet derived endothelial growth factor (PD ECGF); Prognosis; Thymidine phosphorylase (dThdPase)

Indexed keywords

CD34 ANTIGEN; MONOCLONAL ANTIBODY; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; TEGAFUR; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA;

ADENOCARCINOMA; AGED; BLOTTING, WESTERN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PLATELET-DERIVED GROWTH FACTOR; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; THYMIDINE PHOSPHORYLASE;

EID: 0030606313     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04482-5     Document Type: Article

References (45)

1. [1] Folkman, J. (1986) How is blood vessel growth regulated in normal and neoplastic tissue?, (G.H.A. Clowes Memorial Award Lecture). Cancer Res., 46, 467-473.
2. [2] Folkman, J. (1990) What is the evidence that tumors are angiogenesis dependent?, J. Natl. Cancer Inst., 82, 4-6.
3. [3] Tanigawa, N., Amaya, H., Matsumura, M., Shimomatsuya, T., Horiuchi, T., Muraoka, R. and Iki, M. (1996) Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas, Cancer Res., 56, 2671-2676.
4. [4] Furukawa, T., Yoshimura, A., Sumizawa, T., Haraguchi, M., Akiyama, S., Fukui, K., Ishizawa, M. and Yamada, K.(1992) Angiogenic factor. Nature (London), 356, 668.
5. [5] Zimmerman, M. and Seidenber, J.(1964) Deoxyribosyl transfer. J. Biol. Chem., 239, 2618-2621.
6. [6] Pauly, J.L., Paolini, N.S., Ebarb, R.L. and Germain, M.J. (1978) Elevated thymidine phosphorylase activity in the plasma and ascites fluids of tumor-bearing animals, Proc. Soc. Exp. Biol. Med., 157, 262-267.
7. [7] Miwa, M., Nishimura, J., Kamiyama, T. and Ishitsuka, H. (1987) Conversion of 5′-deoxyfluorouridine to 5-FU by pyrimidine nucleoside phosphorylases in normal and tumor tissues from rodent bearing tumors and cancer patients, Jpn. J. Cancer Chemother., 14, 2924-2929.
8. [8] Yoshimura, A., Kuwazuru, Y., Furukawa, T., Yoshida, H., Yamada, K. and Akiyama, S. (1990) Purification and tissue distribution of human thymidine phosphorylase: high expression in lymphocytes, reticulocytes and tumors, Biochim. Biophys. Acta, 1034, 107-113.
9. [9] Reynolds, K., Farzaneh, F., Collins, W.P., Capbell, S., Bourne, T.H., Lawton, F., Moghaddam, A., Harris, A.H. and Bicknell, R. (1994) Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor, J. Natl. Cancer Inst., 86, 1234-1238.
10. [10] Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risaw, W. and Heldin, C.H. (1989) Identification of angiogenic activity and the cloning and expression of platelete-derived endothelial-cell growth factor, Nature (London), 338, 557-562.
11. [11] Toi, M., Hoshina, S., Taniguchi, T., Yamamoto, Y., Ishitsuka, H. and Tominaga, T. (1995) Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer, Int. J. Cancer, 64, 79-82.
12. [12] Takebayashi, Y., Yamada, K., Maruyama, I., Fujii, R., Akiyama, S. and Aikou, T. (1995) The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas, Cancer Lett., 92, 1-7.
13. [13] Japanese Research Society for Gastric Cancer (1993) The General Rules for Gastric Cancer Study, 12th edn. Kanehara Public Co., Tokyo.
14. [14] Kato, Y., Matsukawa, S., Muraoka, R. and Tanigawa, N. (1996) Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet derived-endothelial cell growth factor/thymidine phosphorylase cDNA. Br. J. Cancer, in press.
15. [15] Usuki, K., Saras, J., Waltenberger, J., Miyazono, K., Pierce, G., Thomason, A. and Heldin, C.-H. (1992) Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity, Biochem. Biophys. Res. Commun., 184, 1311-1316.
16. [16] Moghaddam, A. and Bicknell, R. (1992) Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity, Biochemistry, 31, 12141-12146.
17. [17] Sumizawa, T., Furukawa, T., Haraguchi, M., Yoshimura, A., Takeyasu, A., Ishizawa, M., Yamada, Y. and Akiyama, S. (1993) Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor, J. Biochem., 114, 9-14.
18. [18] Finnis, C., Dodsworth, N., Pollitt, C.E., Carr, G. and Sleep, D. (1993) Thymidine phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity, Eur. J. Biochem., 212, 201-210.
19. [19] Moghaddam, A., Zhang, H.-T., Fan, T.-P.D., Hu, D.-E.H., Lees, V.C., Turley, H., Fox, S.B., Gatter, K.C., Harris, A.L. and Bicknell, R. (1995) Thymidine phosphorylase is angiogenic and promotes tumor growth, Proc. Natl. Acad. Sci. USA, 92, 998-1002.
20. [20] Miyadera, K., Sumizawa, T., Haraguchi, M., Yoshida, H., Konstanty, W., Yamada, Y. and Akiyama, S. (1995) Role of thymidine phosphorylase activity in the angiogenetic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase, Cancer Res., 55, 1687-1690.
21. [21] Haraguchi, M., Miyadera, K., Uemura, K., Sumizawa, T., Furukawa, T., Yamada, K., Akiyama, S. and Yamada, Y. (1994) Angiogenic activity of enzymes, Nature (London), 368, 198.
22. [22] Srivastava, A., Laidler, P., Hughes, L.E., Woodcock, J. and Shedden, E.J. (1986) Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study, Eur. J. Cancer Clin. Oncol., 22, 1205-1209.
23. [23] Weidner, N., Semple, J.P., Welch, W.R. and Folkman, J. (1991) Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma, N. Engl. J. Med., 324, 1-8.
24. [24] Macchiarini, P., Fontanini, G., Hardin, M.J., Squartini, F. and Angeletti, C.A. (1992) Relation of neovascularization to metastasis of non-small-cell lung cancer, Lancet, 340, 145-146.
25. [25] Weidner, N., Folkman, J., Pozza, F., Bevilaqua, P., Allred, E.N., Moore, D.H., Meli, S. and Gasparini, G. (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma, J. Natl. Cancer Inst., 84, 1875-1887.
26. [26] Toi, M., Kashitani, J. and Tominaga, T. (1993) Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma, Int. J. Cancer, 55, 371-374.
27. [27] Hollingsworth, H.C., Kohn, E.C., Steinberg, S.M., Rothenberg, M.L. and Merino, M.J. (1995) Tumor angiogenesis in advanced stage ovarian carcinoma, Am. J. Pathol., 147, 33-41.
28. [28] Maeda, K., Chung, Y.-S., Takatsuka, S., Ogawa, Y., Sawada, T., Yamashita, Y., Onoda, N., Kato, Y., Nitta, A., Arimoto, Y., Kondo, Y. and Sawa, M. (1995) Tumor angiogenesis as a predictor of recurrence in gastric carcinoma, J. Clin. Oncol., 13, 477-481.
29. [29] Anthony, P.P. and Ramani, P. (1991) Endothelial markers in malignant vascular tumours of the liver, superiority of QB-END/10 over von Willebrand factor and Ulex europaeus agglutinin 1, J. Clin. Pathol., 44, 29-32.
30. [30] Heldin, N.H., Usuki, K., Bergh, J., Westermark, B. and Heldin, C.H. (1993) Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung-carcinoma cell lines, Brit. J. Cancer, 68, 708-711.
31. [31] Connolly, D.T. (1991) Vascular permeability factor: a unique regulator of blood vessel function, J. Cell Biochem., 47, 219-223.
32. [32] Ohtani, H., Nakamura, S., Watanabe, Y., Mizoi, T., Saku, T. and Nagura, H. (1993) Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract, Lab. Invest., 68, 520-527.
33. [33] Grant, D.S., Kleinman, H.K., Goldberg, I.D., Bhargava, M.M., Nickoloff, B.J., Kineslla, J.R., Polverini, P.L. and Rosen, E.M. (1993) Scatter factor induces blood vessel formation in vivo, Proc. Natl. Acad. Sci. USA, 90, 1937-1941.
34. [34] Maiden, L.T., Novak, U. and Burgess, A.W. (1989) Expression of transforming growth factor alpha messenger RNA in the normal and neoplastic gastroinestinal tract, Int. J. Cancer. 43, 380-384.
35. [35] O'Reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H. and Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma, Cell, 79, 315-328.
36. [36] Singh, R.K., Bucana, C.D., Gutman, M., Fan, D., Wilson, M.R. and Fidler, I.J. (1994) Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells, Am. J. Pathol., 145, 365-374.
37. [37] Dameron, K., Volpert, O., Tainsky, M. and Bouck, N. (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1, Science, 265, 1582-1585.
38. [38] Folkman, J. (1983) Angiogenesis: initiation and modulation, Symp. Fundam. Cancer Res., 36, 201-208.
39. [39] Ezokowitz, R.A.V., Mulliken, J.B. and Folkman, J. (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy, N. Engl. J. Med., 326, 1456-1463.
40. [40] Haraguchi, M., Furukawa, T., Sumizawa, T. and Akiyama, S. (1993) Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites, Cancer Res., 53, 5680-5683.
41. [41] Fidler, I.J. and Ellis, L.M. (1994) The implications of angiogenesis of the biology and therapy of cancer metastasis, Cell, 79, 185-188.
42. [42] Brown, L.F., Berse, B., Jackman, R.W., Tognazzi, K., Manseau, E.J., Senger, D.R. and Dvorak, H. (1993) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract, Cancer Res., 53, 4727-4735.
43. [43] Takahashi, Y., Kitadai, Y., Bucana, C.D., Cleary, K.R. and Ellis, L.M. (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer, Cancer Res., 55, 3964-3968.
44. [44] Kim, K.J., Li, B., Winer, J., Armanim, M., Gillett, N., Phillips, H.S. and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo, Nature, 362, 841-844.
45. [45] Tanigawa, N., Amaya, H., Matsumura, M. and Shimomatsuya, T. (1996) Correlation between expression of vascular endothelial growth factor and tumor vascularity and patient's outcome in human gastric carcinoma. J. Clin. Oncol., in press.